AZTherapies Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:AZTherapies Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11231
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AZTherapies Inc (AZTherapies) is a clinical-stage drug development company that offers discovery, development and commercialization of novel Alzheimer’s disease therapeutics. The company’s product pipeline includes the lead product candidate ALZT-OP1, besides ALZT-Patch, ALZT-QoL, AZHALER-D for the early prevention of Alzheimer’s disease; and ALZT-OP1a, to treat post stroke cognitive impairment (PSCI). ALZT-OP1 is a combination therapy consisting of two re-engineered drugs, in which drug A inhibits beta-amyloid peptide polymerization, and lowers cytokine production, while drug B inhibits the neuroinflammatory response. AZTherapies is headquartered in Boston, Massachusetts, the US.

AZTherapies Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AZTherapies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
AZTherapies Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
AZTherapies Raises USD7.7 Million in Venture Financing 10
AZTherapies Raises Additional USD8.4 Million in Venture Financing 11
AZTherapies Raises USD1.6 Million in Venture Financing 12
AZTherapies Raises Additional USD2.9 Million in Venture Financing 13
AZTherapies Raises USD3.6 Million in Venture Financing 14
AZTherapies Raises Additional USD2.3 Million in Venture Financing 15
AZTherapies Raises USD13.8 Million in Venture Financing 16
AZTherapies Raises USD6 Million in Venture Financing 17
AZTherapies Inc – Key Competitors 18
AZTherapies Inc – Key Employees 19
AZTherapies Inc – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Corporate Communications 21
Oct 31, 2017: AZTherapies appoints Karen Reeves, MD as President and Chief Medical Officer 21
Clinical Trials 22
Jan 31, 2018: A new publication confirms AZTherapies’s innovative drug combination approach to address the neuroinflammation response via neuro-immunology and amyloid beta accumulation associated with neurodegeneration and Alzheimer’s disease 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
AZTherapies Inc, Pharmaceuticals & Healthcare, Key Facts 2
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AZTherapies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AZTherapies Inc, Deals By Therapy Area, 2012 to YTD 2018 8
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
AZTherapies Raises USD7.7 Million in Venture Financing 10
AZTherapies Raises Additional USD8.4 Million in Venture Financing 11
AZTherapies Raises USD1.6 Million in Venture Financing 12
AZTherapies Raises Additional USD2.9 Million in Venture Financing 13
AZTherapies Raises USD3.6 Million in Venture Financing 14
AZTherapies Raises Additional USD2.3 Million in Venture Financing 15
AZTherapies Raises USD13.8 Million in Venture Financing 16
AZTherapies Raises USD6 Million in Venture Financing 17
AZTherapies Inc, Key Competitors 18
AZTherapies Inc, Key Employees 19

List of Figures
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[AZTherapies Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • HUK-COBURG-Versicherungsgruppe:企業の戦略・SWOT・財務情報
    HUK-COBURG-Versicherungsgruppe - Strategy, SWOT and Corporate Finance Report Summary HUK-COBURG-Versicherungsgruppe - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Physiotherapy Associates Inc-製薬・医療分野:企業M&A・提携分析
    Summary Physiotherapy Associates Inc (Physiotherapy Associates) is a healthcare service provider that offers physical therapy services. The center offers services such as aquatic therapy, disability evaluation, dry needling, hand therapy, neurologic rehabilitation, pediatric rehabilitation, TMJ diso …
  • Fifth Third Bancorp:企業のM&A・事業提携・投資動向
    Fifth Third Bancorp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Fifth Third Bancorp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Ego Pharmaceuticals Pty Ltd:企業の戦略的SWOT分析
    Ego Pharmaceuticals Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Obuv Rossii OOO (OBUV):企業の財務・戦略的SWOT分析
    Obuv Rossii OOO (OBUV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Zain Group:企業の戦略・SWOT・財務情報
    Zain Group - Strategy, SWOT and Corporate Finance Report Summary Zain Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Prothena Corp Plc (PRTA):製薬・医療:M&Aディール及び事業提携情報
    Summary Prothena Corp Plc (Prothena) is a clinical biotechnology company, which discovers, develops and markets novel medicines that are indicated for the treatment of diseases associated with neuroscience and orphan diseases. The company develops monoclonal antibodies directed specifically at disea …
  • TPI Composites Inc (TPIC):企業の財務・戦略的SWOT分析
    TPI Composites Inc (TPIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Pioneer Energy Services Corp (PES):石油・ガス:M&Aディール及び事業提携情報
    Summary Pioneer Energy Services Corp (Pioneer) is an oilfield services company that provides land contract drilling and production services. It provides drilling rigs, crew and the ancillary equipment to operate rigs. Its production services include wireline, well servicing and coiled tubing. The co …
  • Imaging Dynamics Company Ltd (IDL)-医療機器分野:企業M&A・提携分析
    Summary Imaging Dynamics Company Ltd (IDC) is a medical technology company that offers solutions in medical imaging and digital radiography technology. The company provides flat panel technology, CCD technology, 2200 X-series, 1600 Plus X-series, 1600 X-series, 1590 X-series, image processing softwa …
  • Bauer AG (B5A)
    Bauer AG (B5A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Purity Wholesale Grocers Inc:企業の戦略的SWOT分析
    Purity Wholesale Grocers Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • RSWM Ltd. (RSWM):企業の財務・戦略的SWOT分析
    RSWM Ltd. (RSWM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • The Ensign Group Inc (ENSG):企業の財務・戦略的SWOT分析
    The Ensign Group Inc (ENSG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Novartis AG:企業のM&A・事業提携・投資動向
    Novartis AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Novartis AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Endonovo Therapeutics Inc (ENDV):医療機器:M&Aディール及び事業提携情報
    Summary Endonovo Therapeutics Inc (Endonovo Therapeutics) is a commercial stage development company that offers non-invasive medical devices and equipment. The company’s products include Electroceutical Therapy a FDA-Cleared for the palliative treatment of pain and post-surgical edema and CE Marked …
  • University Health Network-製薬・医療分野:企業M&A・提携分析
    Summary University Health Network (UHN) is a health care institution that provides patient care, research and educational services, and patient support services. It offers health care services such as palliative care, pharmacy and telehealth. UHN also provides specialized program services, accessibi …
  • Changmao Biochemical Engineering Co., Ltd:戦略・SWOT・企業財務分析
    Changmao Biochemical Engineering Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary Changmao Biochemical Engineering Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • AB Volvo:戦略・SWOT・企業財務分析
    AB Volvo - Strategy, SWOT and Corporate Finance Report Summary AB Volvo - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Hana Financial Group Inc.:企業の戦略・SWOT・財務分析
    Hana Financial Group Inc. - Strategy, SWOT and Corporate Finance Report Summary Hana Financial Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆